Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
RNA Pol II Degradation Activates Cell Death
2026-08-22
The preprint argues that RNA polymerase II degradation can activate cell death through a mechanism that is not simply a consequence of transcriptional shutdown. Its experimental logic separates loss of transcription from loss of the Pol II protein pool, providing a framework for interpreting cytotoxicity in transcription-targeting and cancer biology research.
-
JAK Inhibitors and Endothelial Cardiovascular Effects
2026-08-22
A 2025 ACR Open Rheumatology study compared six JAK inhibitors in cytokine-stimulated human endothelial cells and found that reducing IL-6 did not uniformly normalize adhesion, coagulation, or apoptosis responses. The findings support dose- and inhibitor-specific interpretation of vascular effects, with important implications for inflammatory disorder research and cardiovascular risk models.
-
Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells
2026-08-21
The reference study introduced a phenotypic screening and delivery strategy to reduce SPP1 expression in tumor-associated macrophages rather than relying on broad macrophage depletion. Its lead compound, CANDI460, was incorporated into a TAM-avid nanoformulation that lowered SPP1 in vitro and in vivo and produced tumor remissions in multiple murine models, providing a useful framework for tumor microenvironment macrophage modulation.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-20
Build a quantitative mRNA delivery workflow that separates cellular uptake from functional protein expression in the same experiment. This dual-reporter reagent combines Cy5 tracking with Firefly Luciferase output, making it useful for transfection optimization, intracellular trafficking, and translational vaccine research.
-
Removing Pollen Interference in EEM Bioaerosol Detection
2026-08-20
Zhang et al. developed a fluorescence-data transformation and random-forest workflow to reduce pollen interference during hazardous bioaerosol classification. In the reference study, fast Fourier transform processing improved classification performance to 89.24%, supporting more reliable discrimination of selected pathogens and toxins.
-
Tetracycline Hydrochloride Assay Workflows
2026-08-19
Build reproducible bacterial growth, Staphylococcus aureus susceptibility, and skin microbiome workflows with a mechanism-matched tetracycline control. This guide also shows how to distinguish ribosomal translation inhibition from the rapid ROS-driven cancer-cell death reported for carrier-platin.
-
Calcitriol Workflows for VDR and Decidualization
2026-08-19
Use Calcitriol, the active 1,25-dihydroxy vitamin D3 metabolite, to connect vitamin D receptor signaling with endometrial decidualization, immune modulation research, and cancer pathway assays. This practical guide emphasizes solvent handling, time-course design, orthogonal readouts, and troubleshooting for reproducible results.
-
EdU Imaging Kits (HF594): S-Phase in Context
2026-08-18
EdU Imaging Kits (HF594) enable precise S-phase DNA synthesis measurement without harsh DNA denaturation. This guide shows how to interpret proliferation alongside Treg differentiation and metabolic mechanisms highlighted in recent asthma research.
-
Carfilzomib (PR-171) in Proteasome Research
2026-08-18
Carfilzomib (PR-171) enables precise, irreversible proteasome inhibition for studying proteotoxic stress, apoptosis, and combination responses. This workflow translates recent ESCC radiosensitization findings into practical cell-based assays while emphasizing solvent control, orthogonal readouts, and reproducible dosing.
-
MPTP Opening as a Translational Cell-Death Signal
2026-08-17
A mechanistic and strategic guide to using MPTP opening as a functional bridge between mitochondrial dysfunction, intrinsic apoptosis, and translational cell-death research.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-08-17
The 2025 reference study shows that naturally occurring angiotensin peptides can modify SARS-CoV-2 spike-protein binding to AXL, ACE2, and NRP1 in antibody-based assays. Its peptide-truncation and residue-modification strategy identifies angiotensin IV and related shorter peptides as stronger enhancers than the longer Angiotensin I decapeptide, while also defining important limits for interpreting these findings in infection or cardiovascular models.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-16
Liu and colleagues show that social interaction initiates α- and γ-secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus, generating an intracellular NLG1-CTD fragment that supports synaptic remodeling and social memory maintenance. The study combines behavioral, genetic, pharmacological, biochemical, and peptide-rescue approaches to connect extracellular social cues with cofilin-regulated spine plasticity.
-
From Calpain Biology to Translational Cancer Strategy
2026-08-15
Calpain Inhibitor II, ALLM offers a practical way to interrogate protease-dependent apoptosis and protein turnover. This thought-leadership article connects calpain-2–FAK regulation in triple-negative breast cancer with assay strategy in leukemia and lymphoma, while defining what ALLM can—and cannot—prove in translational research.
-
YC-1 Workflows for Hypoxia Cancer Research
2026-08-14
Build more informative hypoxia experiments with YC-1 by pairing HIF-1α pathway measurements with viability, angiogenesis, and soluble guanylyl cyclase readouts. This guide adapts a rigorously staged fluorometric assay framework to improve formulation control, interference testing, dose–response analysis, and mechanism-aware interpretation.
-
H 89 2HCl: Reliable PKA Pathway Assays
2026-08-14
Learn how H 89 2HCl (SKU B2190) can clarify cAMP/PKA signaling in viability, proliferation, phosphorylation, and osteoclastogenesis workflows. This scenario-based guide covers solvent compatibility, concentration selection, assay controls, off-target interpretation, and practical supplier evaluation.